Anaplastic thyroid cancer epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{Ammu}} | {{CMG}}; {{AE}} {{Ammu}} | ||
==Overview== | ==Overview== | ||
The incidence of follicular thyroid cancer is estimated to be 0.82 per 100 000 person-years. Females are more commonly affected with follicular thyroid cancer than males. The female to male ratio is approximately 3 to 1. The incidence of follicular thyroid cancer increases with age; the median age at diagnosis is 45 to 50 years. | |||
===Incidence=== | ===Incidence=== | ||
===Age=== | ===Age=== | ||
| Line 13: | Line 11: | ||
===Gender=== | ===Gender=== | ||
* Females are more affected than males. | * Females are more affected than males. | ||
==References== | ==References== | ||
Revision as of 06:19, 30 November 2015
|
Anaplastic thyroid cancer Microchapters |
|
Differentiating Anaplastic thyroid cancer from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Anaplastic thyroid cancer epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Anaplastic thyroid cancer epidemiology and demographics |
|
FDA on Anaplastic thyroid cancer epidemiology and demographics |
|
CDC on Anaplastic thyroid cancer epidemiology and demographics |
|
Anaplastic thyroid cancer epidemiology and demographics in the news |
|
Blogs on Anaplastic thyroid cancer epidemiology and demographics |
|
Risk calculators and risk factors for Anaplastic thyroid cancer epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
The incidence of follicular thyroid cancer is estimated to be 0.82 per 100 000 person-years. Females are more commonly affected with follicular thyroid cancer than males. The female to male ratio is approximately 3 to 1. The incidence of follicular thyroid cancer increases with age; the median age at diagnosis is 45 to 50 years.
Incidence
Age
- Typically occurs in the elderly (peak incidence in 6th to 7th decades).[1]
Gender
- Females are more affected than males.